Show/Hide Menu

MorphoSys as a partner

You are here

With its longstanding expertise in antibody engineering, proven development capabilities and leading technologies, MorphoSys is a qualified partner in the industry for drug discovery and the development of biologics.

MorphoSys’s worldwide partnering track record spans a wide range of agreements, from collaborations with academia and innovative biopharmaceutical start-ups to drug discovery alliances with several of the largest pharmaceutical companies like Novartis, Roche, Johnson & Johnson/Janssen, Pfizer, Bayer and Boehringer Ingelheim. For the further development and commercialization of our proprietary clinical-stage programs we have been able to attract GlaxoSmithKline. These productive partnerships have resulted in one of the largest therapeutic antibody pipelines to date.

MorphoSys is dedicated to becoming a fully integrated biopharmaceutical company including late-stage clinical development and marketing/co-promotion of its own drugs. With our goal of engineering the medicines of tomorrow in mind, we are always interested in new collaborations with innovative, science-driven organizations and academic institutions.

MorphoSys has a proven track record of successful alliances including research and development agreements with a number of leading pharmaceutical and biotechnology companies.

Meet us at the following conferences

Mon
09
Mar

BIO-Europe Spring

Paris, France
Mon
04
Thu
07
May

PEGS Boston

Boston, USA
Sat
06
Tue
09
Jun

BIO Convention

San Francisco, USA
Mon
15
Jun

BIO Convention

Philadelphia, USA
Wed
16
Fri
18
Sep

12th International Pharma Licensing Symposium

Berlin, Germany
Mon
02
Wed
04
Nov

BIO-Europe 2015

Munich, Germany
Mon
11
Fri
15
Jan

J.P. Morgan 34th Annual Healthcare Conference

San Francisco, USA

Business Development

Dr. Barbara Krebs-Pohl

Senior Vice President, Head of Business Development

Phone: +49 (0)89 89927 453

Fax: +49 (0)89 89927 5453

Email Contact

Dr. Susanne Wiegel

Director Business Development

Phone: +49 (0)89 89927 453

Fax: +49 (0)89 89927 5453

Email Contact

Dr. Konstantin Petropoulos

Director Business Development

Phone: +49 (0)89 89927 453

Fax: +49 (0)89 89927 5453

Email Contact

Innovation Capital

Sascha Alilovic

Vice President Corporate Finance and Corporate Development

Phone: +49 (0)89 89927 478

Email Contact

Dr. Peter Ruile

Senior Director Corporate Finance and Corporate Development

Phone: +49 (0)89 89927 478

Email Contact

Christoph von Plotho

Manager Corporate Finance and Corporate Development

Phone: +49 (0)89 89927 478

Email Contact

Please note: MorphoSys has a specific procedure for receiving and processing confidential or proprietary information from external sources. Please contact us to obtain the details of this procedure before sending any such information. For that reason, all unsolicited submissions of any kind will be treated as non-confidential and non-proprietary and MorphoSys may freely use any ideas, inventions or anything else contained in your submission.